Agency
Food and Drug Administration
FDADocuments
What this agency has published, newest first.
- Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related InformationNotice
Posted Jun 10, 2026
- Challenges and Solutions in Lot-Level Food Traceability; Public Meeting and Request for CommentsNotice
Posted May 28, 2026 · open until Jul 16, 2026 · 2 comments · 1 awaiting analysis
- Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) Manufactured by Moderna TX Inc.Notice
Posted May 22, 2026 · open until Jun 18, 2026 · 4 comments
- Drug Repurposing for Unmet Medical Needs; Request for InformationNotice
Posted May 12, 2026 · open until Jun 12, 2026 · 323 comments · 14 awaiting analysis
- Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and CommentsNotice
Posted May 1, 2026 · open until Jul 1, 2026 · 16 comments
- List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic ActNotice
Posted May 1, 2026 · open until Jul 1, 2026 · 624 comments · 269 awaiting analysis
- Medical Devices; Exemptions From Premarket Notification: Certain Class II Devices; Request for CommentsNotice
Posted May 1, 2026 · open until Jul 1, 2026 · 7 comments
- ChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a HearingNotice
Posted Apr 30, 2026 · open until Jun 30, 2026 · 67 comments · 5 awaiting analysis
- AI-Enabled Optimization of Early- Phase Clinical Trials Pilot Program; Request for InformationNotice
Posted Apr 29, 2026 · open until Jun 30, 2026 · 121 comments · 1 awaiting analysis
- Commissioner’s National Priority Voucher (CNPV) Pilot Program; Public Hearing; Request for CommentsNotice
Posted Mar 23, 2026 · open until Jun 30, 2026 · 203 comments · 4 awaiting analysis
- Certain Estrogen-Androgen Combination Drugs; Drugs for Human Use; Drug Efficacy Study Implementation; Amendment and Opportunity for HearingNotice
Posted Apr 16, 2003